These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 18375654)
1. Maintaining confidentiality of interim data to enhance trial integrity and credibility. Fleming TR; Sharples K; McCall J; Moore A; Rodgers A; Stewart R Clin Trials; 2008; 5(2):157-67. PubMed ID: 18375654 [TBL] [Abstract][Full Text] [Related]
2. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials. Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941 [TBL] [Abstract][Full Text] [Related]
3. Protecting the confidentiality of interim data: addressing current challenges. Fleming TR Clin Trials; 2015 Feb; 12(1):5-11. PubMed ID: 25475877 [TBL] [Abstract][Full Text] [Related]
9. Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review. Borg Debono V; Mbuagbaw L; Thabane L Trials; 2017 Mar; 18(1):120. PubMed ID: 28279205 [TBL] [Abstract][Full Text] [Related]
10. Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential? Stephens RJ; Langley RE; Mulvenna P; Nankivell M; Vail A; Parmar MK Lung Cancer; 2014 Aug; 85(2):116-8. PubMed ID: 24908333 [TBL] [Abstract][Full Text] [Related]
11. Futility approaches to interim monitoring by data monitoring committees. Demets DL Clin Trials; 2006; 3(6):522-9. PubMed ID: 17170036 [TBL] [Abstract][Full Text] [Related]
12. How to construct an optimal interim report: What the data monitoring committee does and doesn't need to know. Neaton JD; Grund B; Wentworth D Clin Trials; 2018 Aug; 15(4):359-365. PubMed ID: 29552920 [TBL] [Abstract][Full Text] [Related]
13. A major trial needs three statisticians: why, how and who? Pocock SJ Stat Med; 2004 May; 23(10):1535-9. PubMed ID: 15122734 [TBL] [Abstract][Full Text] [Related]
14. The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias. Tharmanathan P; Calvert M; Hampton J; Freemantle N BMC Med Res Methodol; 2008 Mar; 8():12. PubMed ID: 18366697 [TBL] [Abstract][Full Text] [Related]
15. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study. Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484 [TBL] [Abstract][Full Text] [Related]